Advertisement

Topics

Bristol-Myers strengthens oncology pipeline with $300 million, plus milestones, acquisition

08:27 EDT 4 Aug 2017 | thePharmaLetter

Bristol-Myers Squibb says it will acquire IFM Therapeutics, a venture-backed biotech focused on developing…

Original Article: Bristol-Myers strengthens oncology pipeline with $300 million, plus milestones, acquisition

NEXT ARTICLE

More From BioPortfolio on "Bristol-Myers strengthens oncology pipeline with $300 million, plus milestones, acquisition"

Quick Search
Advertisement
 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...